Error: Could not add to watchlist. X

Celyad

+ Watchlist
CARD:BB
Ticker Change
CARD:BB has changed to a new ticker symbol
EUR
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Celyad is a biopharmaceutical company. The Company develops and commercializes cell based regenerative therapies for the treatment of cardiovascular diseases.
ADDRESS
Rue Edouard Belin 12
Axis Business Parc
Mont-Saint-Guibert, 1435
Belgium
PHONE
32-1-039-41-00
  • Christian Homsy
    CEO/Exec Dir
  • Patrick Jeanmart
    CFO/Investors Relations
  • Warren Sherman
    Chief Medical Officer
  • Peter De Waele
    VP:Research & Development
  • Vincent Brichard
    VP:Immuno-Oncology
Show More